Return
PERIPHERAL MEASURABLE RESIDUAL DISEASE ACTIVITY ASSESSMENT BY MALDI-TOF MASS SPECTROMETRY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA IN THE PHASE 3 GMMG-HD7 TRIAL
J
G
H
R
F
B
B
S
V
H
M
L
H
S
P
B
M
L
H
T
G
K
M
S
K
M
G
R
L
R
H
B
F
W
S
M
DOI:.png)
Abstract
En
Journal
IF:
7.9
Papers:
6.4K
Citations:
2.2W
